Pharmaceutical portfolio
Over the last 16 years EPP Ltd have accumulated considerable experience in the custom synthesis of various types of pharmaceutical analytical reference standards on scales ranging from milligrams [for initial identification purposes] to a kilogram [for toxicity, process validation and environmental fate studies].
Listed below are the pharmaceutical actives for which EPP Ltd has experience of synthesising analytical standards. The number of different standards produced for each active varies. For further further infomation, please contact us
| Controlled Drugs | Non-Controlled Drugs |
| Codeine | Atropine |
| Morphine | Flucloxacillin |
| Cocaine | Trimethoprim |
| Methadone | Propetamphos |
| Remifentanil | Deltamethrin |
| Naltrexone | Permethrin |
| Sufentanil | Cypermethrin |
| Fentanyl | Oxfendazole |
| Oxycodone | Fenbendazole |
| Diprenorphine | Amitraz |
| Alfentanil | Imidocarb |
| Dexamphetamine | Albendazole |
| MDMA | Pralidoxime Mesylate |
| Apomorphine | |
| Amoxicillin | |
| Dihydroergotamine | |
| Alfaxalone | |
| Alfadalone Acetate | |
| Cyromazine | |
| Fipronil | |
| Gemfibrozil | |
| Avizafone | |
| Tetrabenazine | |
| Benzydamine | |
| Mercaptopurine | |
| Dacarbazine | |
| Benztropine Mesylate | |
| Ibuprofen | |
| Ranolazine | |
| Galanthamine | |
| Closantel | |
| HI-6 | |
| Papaverine | |
| Carprofen | |
| Risperidone | |
| Ibogaine | |
| Methotrexate | |
| Galegine | |
| Chloroquine |